Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of combining Camrelizumab with Apatinib in patients with gastric cancer and gastroesophageal junc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gastric Cancer | Phase 3 | Status: RECRUITING